SENORES

Senores Pharmaceuticals has achieved a significant milestone as its stock price reached an all-time high of Rs. 830.3 on November 7, 2025. This remarkable performance underscores the company's strong position within the pharmaceuticals and biotechnology sector. Today, Senores Pharmaceuticals outperformed its sector by 3.45%, marking a notable increase of 3.04% from the previous day. The stock has shown consistent growth, gaining 8.28% over the last two days alone. In terms of moving averages, Senores Pharmaceuticals is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a robust upward trend. In the broader market context, Senores Pharmaceuticals has demonstrated impressive performance metrics. Over the past month, the stock has surged by 17.27%, significantly outpacing the Sensex, which saw a modest increase of 1.51%. Year-to-date, the company has delivered a remarkable 46.01% return, further solidifying its strong market presence. This achievement reflects the company's commitment to excellence and innovation in the pharmaceutical industry.